Abstract
The intestinal hologenome lies at the center of intestinal homeostasis and disease. It is the sum of the host genome and the intestinal microbiome. During the last decade we came to appreciate the pivotal role of the microbiome in intestinal inflammation and concomitant diseases. Moreover environmental factors, predominantly diet, affect the microbiome and the host immune responses. Thus manipulation of intestinal microbiota and environmental factors are rightfully the focus of current research. The study of the hologenome necessitates not only clinical assessments but also the use of model organisms, for example, mice and flies. Despite the limitations imposed by the evolutionary distance between flies and mammals, Drosophila research provided us during the last few years with a wealth of information regarding intestinal inflammation and the role of microbiota. Conserved aspects of intestinal homeostasis and disease between flies and mice, for example in signalling pathways, the intestinal defence responses and the role of microbiota, consolidate and may advance the principles that govern intestinal inflammation in humans.
An erratum of this chapter can be found under DOI 10.1007/978-3-319-18326-8_16
An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-3-319-18326-8_16
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361(21):2066–2078
Alzoghaibi MA, Al-Mofleh IA, Al-Jebreen AM (2008) Neutrophil chemokines GCP-2 and GRO-alpha in patients with inflammatory bowel disease. J Dig Dis 9(3):144–148
Amir Shaghaghi M, Bernstein CN, Serrano Leon A, El-Gabalawy H, Eck P (2014) Polymorphisms in the sodium-dependent ascorbate transporter gene SLC23A1 are associated with susceptibility to Crohn disease. Am J Clin Nutr 99(2):378–383
Andersen V, Olsen A, Carbonnel F, Tjonneland A, Vogel U (2012) Diet and risk of inflammatory bowel disease. Dig Liver Dis 44(3):185–194
Anderson CA, Boucher G, Lees CW, Franke A, D’Amato M, Taylor KD et al (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43(3):246–252
Aoi W, Naito Y, Takagi T, Tanimura Y, Takanami Y, Kawai Y et al (2013) A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut 62(6):882–889
Apidianakis Y, Pitsouli C, Perrimon N, Rahme L (2009) Synergy between bacterial infection and genetic predisposition in intestinal dysplasia. Proc Natl Acad Sci U S A 106(49):20883–20888
Apidianakis Y, Rahme LG (2011) Drosophila melanogaster as a model for human intestinal infection and pathology. Dis Model Mech 4(1):21–30
Araki A, Kanai T, Ishikura T, Makita S, Uraushihara K, Iiyama R et al (2005) MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol 40(1):16–23
Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi Porro G (2006) Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 55(1):47–53
Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ et al (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338(6103):120–123
Asakura H, Suzuki K, Kitahora T, Morizane T (2008) Is there a link between food and intestinal microbes and the occurrence of Crohn’s disease and ulcerative colitis? J Gastroenterol Hepatol 23(12):1794–1801
Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y et al (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331(6015):337–341
Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307(5717):1915–1920
Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M et al (2010) Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease. Gastroenterology 138(2):463–468
Balish E, Warner T (2002) Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 160(6):2253–2257
Bangi E, Pitsouli C, Rahme LG, Cagan R, Apidianakis Y (2012) Immune response to bacteria induces dissemination of Ras-activated Drosophila hindgut cells. EMBO Rep 13(6):569–576
Bank S, Skytt Andersen P, Burisch J, Pedersen N, Roug S, Galsgaard J et al (2014) Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish Cohort. PLoS ONE 9(6):98815
Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, Allez M et al (2007) CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 117(6):1566–1574
Bassaganya-Riera J, DiGuardo M, Viladomiu M, de Horna A, Sanchez S, Einerhand AW et al (2011) Soluble fibers and resistant starch ameliorate disease activity in interleukin-10-deficient mice with inflammatory bowel disease. J Nutr 141(7):1318–1325
Beaudoin M, Goyette P, Boucher G, Lo KS, Rivas MA, Stevens C et al (2013) Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet 9(9):e1003723
Benight NM, Stoll B, Chacko S, da Silva VR, Marini JC, Gregory JF et al (2011) B-vitamin deficiency is protective against DSS-induced colitis in mice. Am J Physiol Gastrointest Liver Physiol 301(2):G249–G259
Bennike T, Birkelund S, Stensballe A, Andersen V (2014) Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies. World J Gastroenterol 20(12):3231–3244
Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G et al (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98(4):1010–1020
Bernstein CN, Fried M, Krabshuis JH, Cohen H, Eliakim R, Fedail S et al (2010) World gastroenterology organization practice guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis 16(1):112–124
Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M et al (2005) VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100(7):1539–1546
Bilski J, Brzozowski B, Mazur-Bialy A, Sliwowski Z, Brzozowski T (2014) The role of physical exercise in inflammatory bowel disease. Biomed Res Int 2014:429031
Biteau B, Hochmuth CE, Jasper H (2008) JNK activity in somatic stem cells causes loss of tissue homeostasis in the aging Drosophila gut. Cell Stem Cell 3(4):442–455
Biteau B, Jasper H (2011) EGF signaling regulates the proliferation of intestinal stem cells in Drosophila. Development 138(6):1045–1055
Blair SA, Kane SV, Clayburgh DR, Turner JR (2006) Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest 86(2):191–201
Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, Donermeyer DL et al (2011) Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9(5):390–403
Blow NS, Salomon RN, Garrity K, Reveillaud I, Kopin A, Jackson FR et al (2005) Vibrio cholerae infection of Drosophila melanogaster mimics the human disease cholera. PLoS Pathog 1(1):e8
Bonnay F, Cohen-Berros E, Hoffmann M, Kim SY, Boulianne GL, Hoffmann JA et al (2013) Big bang gene modulates gut immune tolerance in Drosophila. Proc Natl Acad Sci U S A 110(8):2957–2962
Bosco-Drayon V, Poidevin M, Boneca IG, Narbonne-Reveau K, Royet J, Charroux B (2012) Peptidoglycan sensing by the receptor PGRP-LE in the Drosophila gut induces immune responses to infectious bacteria and tolerance to microbiota. Cell Host Microbe 12(2):153–165
Brant SR (2011) Update on the heritability of inflammatory bowel disease: the importance of twin studies. Inflamm Bowel Dis 17(1):1–5
Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V et al (2011) A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn’s disease. Nat Genet 43(3):242–245
Buchon N, Broderick NA, Chakrabarti S, Lemaitre B (2009a) Invasive and indigenous microbiota impact intestinal stem cell activity through multiple pathways in Drosophila. Genes Dev 23(19):2333–2344
Buchon N, Broderick NA, Poidevin M, Pradervand S, Lemaitre B (2009b) Drosophila intestinal response to bacterial infection: activation of host defense and stem cell proliferation. Cell Host Microbe 5(2):200–211
Buisine MP, Desreumaux P, Debailleul V, Gambiez L, Geboes K, Ectors N et al (1999) Abnormalities in mucin gene expression in Crohn’s disease. Inflamm Bowel Dis 5(1):24–32
Burisch J, Jess T, Martinato M, Lakatos PL, ECCO-EpiCom (2013) The burden of inflammatory bowel disease in Europe. J Crohns Colitis 7(4):322–337
Burisch J, Pedersen N, Cukovic-Cavka S, Brinar M, Kaimakliotis I, Duricova D et al (2014) East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 63(4):588–597
Cabrera S, Fernandez AF, Marino G, Aguirre A, Suarez MF, Espanol Y et al (2013) ATG4B/autophagin-1 regulates intestinal homeostasis and protects mice from experimental colitis. Autophagy 9(8):1188–1200
Cahill RJ, Foltz CJ, Fox JG, Dangler CA, Powrie F, Schauer DB (1997) Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 65(8):3126–3131
Campbell BJ, Yu LG, Rhodes JM (2001) Altered glycosylation in inflammatory bowel disease: a possible role in cancer development. Glycoconj J 18(11–12):851–858
Carrier J, Medline A, Sohn KJ, Choi M, Martin R, Hwang SW et al (2003) Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2-and beta(2)-microglobulin-deficient mice. Cancer Epidemiol Biomarkers Prev 12(11 Pt 1):1262–1267
Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F (1995) Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 154(5):2434–2440
Castiglione F, Rispo A, Di Girolamo E, Cozzolino A, Manguso F, Grassia R et al (2003) Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn’s disease. Aliment Pharmacol Ther 18(11–12):1107–1112
Chande N, Tsoulis DJ, MacDonald JK (2013) Azathioprine or 6-mercaptopurine for induction of remission in Crohn’s disease. Cochrane Database Syst Rev 4:CD000545
Chandler JA, Lang JM, Bhatnagar S, Eisen JA, Kopp A (2011) Bacterial communities of diverse Drosophila species: ecological context of a host-microbe model system. PLoS Genet 7(9):e1002272
Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM et al (2008) Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 197(3):435–438
Chatterjee D, Chaudhuri K (2013) Vibrio cholerae O395 outer membrane vesicles modulate intestinal epithelial cells in a NOD1 protein-dependent manner and induce dendritic cell-mediated Th2/Th17 cell responses. J Biol Chem 288(6):4299–4309
Chiba M, Abe T, Tsuda H, Sugawara T, Tsuda S, Tozawa H et al (2010) Lifestyle-related disease in Crohn’s disease: relapse prevention by a semi-vegetarian diet. World J Gastroenterol 16(20):2484–2495
Christofi T, Apidianakis Y (2012) Ras-oncogenic Drosophila hindgut but not midgut cells use an inflammation-like program to disseminate to distant sites. Gut Microbes 4(1):1–6
Coccia M, Harrison OJ, Schiering C, Asquith MJ, Becher B, Powrie F et al (2012) IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med 209(9):1595–1609
Connelly TM, Koltun WA, Berg AS, Hegarty JP, Brinton D, Deiling S et al (2013) A single nucleotide polymorphism in the STAT5 gene favors colonic as opposed to small-bowel inflammation in Crohn’s disease. Dis Colon Rectum 56(9):1068–1074
Cordero JB, Macagno JP, Stefanatos RK, Strathdee KE, Cagan RL, Vidal M (2010) Oncogenic Ras diverts a host TNF tumor suppressor activity into tumor promoter. Dev Cell 18(6):999–1011
Costello CM, Mah N, Hasler R, Rosenstiel P, Waetzig GH, Hahn A et al (2005) Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med 2(8):e199
Cronin SJ, Nehme NT, Limmer S, Liegeois S, Pospisilik JA, Schramek D et al (2009) Genome-wide RNAi screen identifies genes involved in intestinal pathogenic bacterial infection. Science 325(5938):340–343
D’Amato M, Bruce S, Bresso F, Zucchelli M, Ezer S, Pulkkinen V et al (2007) Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. Gastroenterology 133(3):808–817
Dahan S, Rabinowitz KM, Martin AP, Berin MC, Unkeless JC, Mayer L (2011) Notch-1 signaling regulates intestinal epithelial barrier function, through interaction with CD4 + T cells, in mice and humans. Gastroenterology 140(2):550–559
de Buck van Overstraeten A, Wolthuis A, D’Hoore A (2012) Surgery for Crohn’s disease in the era of biologicals: a reduced need or delayed verdict? World J Gastroenterol 18(29):3828–3832
Deming DA, Leystra AA, Nettekoven L, Sievers C, Miller D, Middlebrooks M et al (2014) PIK3CA and APC mutations are synergistic in the development of intestinal cancers. Oncogene 33(17):2245–2254
Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A et al (2012) Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487(7405):104–108
Dhillon SS, Mastropaolo LA, Murchie R, Griffiths C, Thoni C, Elkadri A et al (2014) Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease. Clin Transl Gastroenterol 5:e46
Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174(6):3237–3246
Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K et al (2012) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis 6(10):965–990
Dignass A, Van Assche G, Lindsay JO, Lemann M, Soderholm J, Colombel JF et al (2010) The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Current management. J Crohns Colitis 4(1):28–62
Dotan I (2010) New serologic markers for inflammatory bowel disease diagnosis. Dig Dis 28(3):418–423
Dubinsky MC, Kugathasan S, Mei L, Picornell Y, Nebel J, Wrobel I et al (2008) Increased immune reactivity predicts aggressive complicating Crohn’s disease in children. Clin Gastroenterol Hepatol 6(10):1105–1111
Edwards LA, O’Neill C, Furman MA, Hicks S, Torrente F, Perez-Machado M et al (2012) Enterotoxin-producing staphylococci cause intestinal inflammation by a combination of direct epithelial cytopathy and superantigen-mediated T-cell activation. Inflamm Bowel Dis 18(4):624–640
Elrod JW, Laroux FS, Houghton J, Carpenter A, Ando T, Jennings MH et al (2005) DSS-induced colitis is exacerbated in STAT-6 knockout mice. Inflamm Bowel Dis 11(10):883–889
Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759–767
Fleshner P, Ippoliti A, Dubinsky M, Vasiliauskas E, Mei L, Papadakis KA et al (2008) Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 6(5):561–568
Foligne B, Nutten S, Grangette C, Dennin V, Goudercourt D, Poiret S et al (2007) Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 13(2):236–243
Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T et al (2004) Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis. Gut 53(7):987–992
Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104(34):13780–13785
Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet 42(12):1118–1125
Froslie KF, Jahnsen J, Moum BA, Vatn MH, IBSEN Group (2007) Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 133(2):412–422
Fuhrer A, Sprenger N, Kurakevich E, Borsig L, Chassard C, Hennet T (2010) Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization. J Exp Med 207(13):2843–2854
Fujisawa M, Oguchi K, Yamaura T, Suzuki M, Cyong JC (2005) Protective effect of hawthorn fruit on murine experimental colitis. Am J Chin Med 33(2):167–180
Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S et al (2007) Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131(1):33–45
Gensollen T, Bourges C, Rihet P, Rostan A, Millet V, Noguchi T et al (2013) Functional polymorphisms in the regulatory regions of the VNN1 gene are associated with susceptibility to inflammatory bowel diseases. Inflamm Bowel Dis 19(11):2315–2325
George RH, Symonds JM, Dimock F, Brown JD, Arabi Y, Shinagawa N et al (1978) Identification of clostridium difficile as a cause of pseudomembranous colitis. Br Med J 1(6114):695
Ghosh S, DeCoffe D, Brown K, Rajendiran E, Estaki M, Dai C et al (2013) Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLoS ONE 8(2):e55468
Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P et al (2003) Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124(5):1202–1209
Giuffrida P, Biancheri P, MacDonald TT (2014) Proteases and small intestinal barrier function in health and disease. Curr Opin Gastroenterol 30(2):147–153
Gkouskou KK, Deligianni C, Tsatsanis C, Eliopoulos AG (2014) The gut microbiota in mouse models of inflammatory bowel disease. Front Cell Infect Microbiol 4:28
Goodhand JR, Wahed M, Mawdsley JE, Farmer AD, Aziz Q, Rampton DS (2012) Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis 18(12):2301–2309
Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD et al (1988) Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut 29(5):588–592
Griga T, Wilkens C, Wirkus N, Epplen J, Schmiegel W, Klein W (2007) A polymorphism in the macrophage migration inhibitory factor gene is involved in the genetic predisposition of Crohn’s disease and associated with cumulative steroid doses. Hepatogastroenterology 54(75):784–786
Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S et al (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15(2):103–113
Groden J, Gelbert L, Thliveris A, Nelson L, Robertson M, Joslyn G et al (1993) Mutational analysis of patients with adenomatous polyposis: identical inactivating mutations in unrelated individuals. Am J Hum Genet 52(2):263–272
Gudmand-Hoyer E, Jarnum S (1970) Incidence and clinical significance of lactose malabsorption in ulcerative colitis and Crohn’s disease. Gut 11(4):338–343
Gunther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H et al (2011) Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 477(7364):335–339
Guo L, Karpac J, Tran SL, Jasper H (2014) PGRP-SC2 promotes gut immune homeostasis to limit commensal dysbiosis and extend lifespan. Cell 156(1–2):109–122
Ha EM, Lee KA, Seo YY, Kim SH, Lim JH, Oh BH et al (2009) Coordination of multiple dual oxidase-regulatory pathways in responses to commensal and infectious microbes in drosophila gut. Nat Immunol 10(9):949–957
Ha EM, Oh CT, Bae YS, Lee WJ (2005) A direct role for dual oxidase in Drosophila gut immunity. Science 310(5749):847–850
Hakansson A, Tormo-Badia N, Baridi A, Xu J, Molin G, Hagslatt ML et al (2014) Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. Clin Exp Med 1:107–120
Halme L, Paavola-Sakki P, Turunen U, Lappalainen M, Farkkila M, Kontula K (2006) Family and twin studies in inflammatory bowel disease. World J Gastroenterol 12(23):3668–3672
Han NY, Choi W, Park JM, Kim EH, Lee H, Hahm KB (2013) Label-free quantification for discovering novel biomarkers in the diagnosis and assessment of disease activity in inflammatory bowel disease. J Dig Dis 14(4):166–174
Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D et al (2006) Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial. Gastroenterology 130(2):323–333
Haramis AP, Begthel H, van den Born M, van Es J, Jonkheer S, Offerhaus GJ et al (2004) De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303(5664):1684–1686
Hegan PS, Mermall V, Tilney LG, Mooseker MS (2007) Roles for Drosophila melanogaster myosin IB in maintenance of enterocyte brush-border structure and resistance to the bacterial pathogen Pseudomonas entomophila. Mol Biol Cell 18(11):4625–4636
Henckaerts L, Cleynen I, Brinar M, John JM, Van Steen K, Rutgeerts P et al (2011) Genetic variation in the autophagy gene ULK1 and risk of Crohn’s disease. Inflamm Bowel Dis 17(6):1392–1397
Hendel J, Nielsen OH (1997) Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am J Gastroenterol 92(7):1170–1173
Henderson P, van Limbergen JE, Wilson DC, Satsangi J, Russell RK (2011) Genetics of childhood-onset inflammatory bowel disease. Inflamm Bowel Dis 17(1):346–361
Henry SC, Daniell X, Indaram M, Whitesides JF, Sempowski GD, Howell D et al (2007) Impaired macrophage function underscores susceptibility to Salmonella in mice lacking Irgm1 (LRG-47). J Immunol 179(10):6963–6972
Hoie O, Wolters FL, Riis L, Bernklev T, Aamodt G, Clofent J et al (2007) Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 132(2):507–515
Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336(6086):1268–1273
Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291(5505):881–884
Hosomi S, Oshitani N, Kamata N, Sogawa M, Okazaki H, Tanigawa T et al (2011) Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis. Clin Exp Immunol 163(2):215–224
Hou JK, Abraham B, El-Serag H (2011) Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 106(4):563–573
Huang SC, Lee CT, Chung BC (2014) Tumor necrosis factor suppresses NR5A2 activity and intestinal glucocorticoid synthesis to sustain chronic colitis. Sci Signal 7(314):ra20
Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A et al (2006) Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci U S A 103(30):11276–11281
Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486(7402):207–214
Hunter CJ, Williams M, Petrosyan M, Guner Y, Mittal R, Mock D et al (2009) Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis. Infect Immun 77(3):1031–1043
Jang JY, Kim HJ, Jung JH, Chae MJ, Kim NH, Lee SK et al (2006) The role of smoking as a risk factor in inflammatory bowel diseases: single center study in Korea. Korean J Gastroenterol 47(3):198–204
Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F (2010) Animal protein intake and risk of inflammatory bowel disease: the E3 N prospective study. Am J Gastroenterol 105(10):2195–2201
Javed S, Mejias-Luque R, Kalali B, Bolz C, Gerhard M (2013) Helicobacter bilis gamma-glutamyltranspeptidase enhances inflammatory stress response via oxidative stress in colon epithelial cells. PLoS ONE 8(8):e73160
Jiang H, Grenley MO, Bravo MJ, Blumhagen RZ, Edgar BA (2011a) EGFR/Ras/MAPK signaling mediates adult midgut epithelial homeostasis and regeneration in Drosophila. Cell Stem Cell 8(1):84–95
Jiang HQ, Kushnir N, Thurnheer MC, Bos NA, Cebra JJ (2002) Monoassociation of SCID mice with Helicobacter muridarum, but not four other enterics, provokes IBD upon receipt of T cells. Gastroenterology 122(5):1346–1354
Jiang H, Patel PH, Kohlmaier A, Grenley MO, McEwen DG, Edgar BA (2009) Cytokine/Jak/Stat signaling mediates regeneration and homeostasis in the Drosophila midgut. Cell 137(7):1343–1355
Jiang H, Przybyszewski J, Mitra D, Becker C, Brehm-Stecher B, Tentinger A et al (2011b) Soy protein diet, but not Lactobacillus rhamnosus GG, decreases mucin-1, trefoil factor-3, and tumor necrosis factor-alpha in colon of dextran sodium sulfate-treated C57BL/6 mice. J Nutr 141(7):1239–1246
Jiang R, Wang H, Deng L, Hou J, Shi R, Yao M et al (2013) IL-22 is related to development of human colon cancer by activation of STAT3. BMC Cancer 13:59
Jones RM, Luo L, Ardita CS, Richardson AN, Kwon YM, Mercante JW et al (2013) Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J 32(23):3017–3028
Jones RM, Wu H, Wentworth C, Luo L, Collier-Hyams L, Neish AS (2008) Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 3(4):233–244
Jones SE, Versalovic J (2009) Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol 9:35
Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY et al (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491(7422):119–124
Jussila A, Virta LJ, Salomaa V, Maki J, Jula A, Farkkila MA (2013) High and increasing prevalence of inflammatory bowel disease in Finland with a clear North-South difference. J Crohns Colitis 7(7):e256–e262
Kaakoush NO, Day AS, Huinao KD, Leach ST, Lemberg DA, Dowd SE et al (2012) Microbial dysbiosis in pediatric patients with Crohn’s disease. J Clin Microbiol 50(10):3258–3266
Kale-Pradhan PB, Zhao JJ, Palmer JR, Wilhelm SM (2013) The role of antimicrobials in Crohn’s disease. Expert Rev Gastroenterol Hepatol 7(3):281–288
Kanai T, Matsuoka K, Naganuma M, Hayashi A, Hisamatsu T (2014) Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods. Korean J Intern Med 29(4):409–415
Kang S, Okuno T, Takegahara N, Takamatsu H, Nojima S, Kimura T et al (2012) Intestinal epithelial cell-derived semaphorin 7A negatively regulates development of colitis via alphavbeta1 integrin. J Immunol 188(3):1108–1116
Kao D, Hotte N, Gillevet P, Madsen K (2014) Fecal microbiota transplantation inducing remission in Crohn’s colitis and the associated changes in fecal microbial profile. J Clin Gastroenterol 48(7):625–628
Kaplan GG, Jackson T, Sands BE, Frisch M, Andersson RE, Korzenik J (2008) The risk of developing Crohn’s disease after an appendectomy: a meta-analysis. Am J Gastroenterol 103(11):2925–2931
Kappelman MD, Moore KR, Allen JK, Cook SF (2013) Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci 58(2):519–525
Karpac J, Biteau B, Jasper H (2013) Misregulation of an adaptive metabolic response contributes to the age-related disruption of lipid homeostasis in Drosophila. Cell Rep 4(6):1250–1261
Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, Tilg H et al (2008) XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134(5):743–756
Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115(3):695–702
Kawabata K, Sugiyama Y, Sakano T, Ohigashi H (2013) Flavonols enhanced production of anti-inflammatory substance(s) by Bifidobacterium adolescentis: prebiotic actions of galangin, quercetin, and fisetin. Biofactors 39(4):422–429
Keshet R, Boursi B, Maoz R, Shnell M, Guzner-Gur H (2009) Diagnostic and prognostic significance of serum C-reactive protein levels in patients admitted to the department of medicine. Am J Med Sci 337(4):248–255
Khan MW, Keshavarzian A, Gounaris E, Melson JE, Cheon EC, Blatner NR et al (2013) PI3 K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer. Clin Cancer Res 19(9):2342–2354
Khanna S, Pardi DS (2012) IBD: Poor outcomes after Clostridium difficile infection in IBD. Nat Rev Gastroenterol Hepatol 9(6):307–308
Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474(7351):307–317
Kim N, Kunisawa J, Kweon MN, Eog Ji G, Kiyono H (2007a) Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation. Clin Immunol 123(1):30–39
Kim SC, Tonkonogy SL, Karrasch T, Jobin C, Sartor RB (2007b) Dual-association of gnotobiotic IL-10-/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm Bowel Dis 13(12):1457–1466
Kirchberger S, Royston DJ, Boulard O, Thornton E, Franchini F, Szabady RL et al (2013) Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 210(5):917–931
Klein A, Eliakim R (2010) Non steroidal anti-inflammatory drugs and inflammatory bowel disease. Pharmaceuticals 3(4):1084–1092
Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G et al (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307(5710):731–734
Koelewijn CL, Schwartz MP, Samsom M, Oldenburg B (2008) C-reactive protein levels during a relapse of Crohn’s disease are associated with the clinical course of the disease. World J Gastroenterol 14(1):85–89
Kohno H, Suzuki R, Curini M, Epifano F, Maltese F, Gonzales SP et al (2006) Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis-related colon carcinogenesis in mice. Int J Cancer 118(12):2936–2942
Kojouharoff G, Hans W, Obermeier F, Mannel DN, Andus T, Scholmerich J et al (1997) Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 107(2):353–358
Komorowski L, Teegen B, Probst C, Aulinger-Stocker K, Sina C, Fellermann K et al (2013) Autoantibodies against exocrine pancreas in Crohn’s disease are directed against two antigens: the glycoproteins CUZD1 and GP2. J Crohns Colitis 7(10):780–790
Konrad A, Rutten C, Flogerzi B, Styner M, Goke B, Seibold F (2004) Immune sensitization to yeast antigens in ASCA-positive patients with Crohn’s disease. Inflamm Bowel Dis 10(2):97–105
Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M et al (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14(2):207–215
Kovacs M, Muller KE, Papp M, Lakatos PL, Csondes M, Veres G (2014) New serological markers in pediatric patients with inflammatory bowel disease. World J Gastroenterol 20(17):4873–4882
Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, Schuermann G et al (2001) Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 194(9):1207–1218
Kronman MP, Zaoutis TE, Haynes K, Feng R, Coffin SE (2012) Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 130(4):e794–e803
Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M et al (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53(11):1617–1623
Kryczek I, Lin Y, Nagarsheth N, Peng D, Zhao L, Zhao E et al (2014) IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L. Immunity 40(5):772–784
Kuester D, Guenther T, Biesold S, Hartmann A, Bataille F, Ruemmele P et al (2010) Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma. Pathol Res Pract 206(9):616–624
Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PM, Imielinski M, Guthery SL et al (2008) Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 40(10):1211–1215
Kullberg MC, Jankovic D, Feng CG, Hue S, Gorelick PL, McKenzie BS et al (2006) IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med 203(11):2485–2494
Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A et al (1998) Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 66(11):5157–5166
Kunde S, Pham A, Bonczyk S, Crumb T, Duba M, Conrad HJr et al (2013) Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 56(6):597–601
Kuraishi T, Binggeli O, Opota O, Buchon N, Lemaitre B (2011) Genetic evidence for a protective role of the peritrophic matrix against intestinal bacterial infection in Drosophila melanogaster. Proc Natl Acad Sci U S A 108(38):15966–15971
Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y et al (2010) Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 151(6):2423–2432
Lakatos PL, Lakatos L (2008) Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol 14(25):3937–3947
Lara-Villoslada F, Debras E, Nieto A, Concha A, Galvez J, Lopez-Huertas E et al (2006) Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clin Nutr 25(3):477–488
LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M (2013) Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol 24(2):160–168
Lee JC, Espeli M, Anderson CA, Linterman MA, Pocock JM, Williams NJ et al (2013a) Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway. Cell 155(1):57–69
Lee KA, Kim SH, Kim EK, Ha EM, You H, Kim B et al (2013b) Bacterial-derived uracil as a modulator of mucosal immunity and gut-microbe homeostasis in Drosophila. Cell 153(4):797–811
Lee KA, Lee WJ (2014) Drosophila as a model for intestinal dysbiosis and chronic inflammatory diseases. Dev Comp Immunol 42(1):102–110
Lemaitre B, Hoffmann J (2007) The host defense of Drosophila melanogaster. Annu Rev Immunol 25:697–743
Lemaitre B, Kromer-Metzger E, Michaut L, Nicolas E, Meister M, Georgel P et al (1995) A recessive mutation, immune deficiency (imd), defines two distinct control pathways in the Drosophila host defense. Proc Natl Acad Sci U S A 92(21):9465–9469
Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA (1996) The dorsoventral regulatory gene cassette spatzle/toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86(6):973–983
Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK et al (2011) Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 17(6):1314–1321
Li CK, Pender SL, Pickard KM, Chance V, Holloway JA, Huett A et al (2004) Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice. J Immunol 173(8):5171–5179
Liehl P, Blight M, Vodovar N, Boccard F, Lemaitre B (2006) Prevalence of local immune response against oral infection in a Drosophila/Pseudomonas infection model. PLoS Pathog 2(6):e56
Lin PW, Myers LE, Ray L, Song SC, Nasr TR, Berardinelli AJ et al (2009) Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radical Biol Med 47(8):1205–1211
Linton L, Karlsson M, Grundstrom J, Hjalmarsson E, Lindberg A, Lindh E et al (2012) HLA-DR(hi) and CCR9 define a pro-inflammatory monocyte subset in IBD. Clin Transl Gastroenterol 3:e29
Luftman K, Hasan N, Day P, Hardee D, Hu C (2009) Silencing of VAMP3 inhibits cell migration and integrin-mediated adhesion. Biochem Biophys Res Commun 380(1):65–70
Ma D, Forsythe P, Bienenstock J (2004) Live Lactobacillus rhamnosus is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 72(9):5308–5314
MacDonald RS, Przybyszewski J (2008) Soy protein diet suppresses COX-2 induction by dextran sodium sulfate in CD-1 mouse colon. FASEB J 22:885
Macho Fernandez E, Valenti V, Rockel C, Hermann C, Pot B, Boneca IG et al (2011) Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60(8):1050–1059
Maconi G, Ardizzone S, Cucino C, Bezzio C, Russo AG, Bianchi Porro G (2010) Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: a case-control study. World J Gastroenterol 16(34):4297–4304
Madsen KL, Fedorak RN, Tavernini MM, Doyle JS (2002) Normal breast milk limits the development of colitis in IL-10-deficient mice. Inflamm Bowel Dis 8(6):390–398
Maerten P, Kwon BS, Shen C, De Hertogh G, Cadot P, Bullens DM et al (2006) Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis. Clin Exp Immunol 143(2):228–236
Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM (2006) Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res 66(2):828–838
Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S (2006) Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 81(11):1462–1471
Makitalo L, Kolho KL, Karikoski R, Anthoni H, Saarialho-Kere U (2010) Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease. Scand J Gastroenterol 45(7–8):862–871
Makitalo L, Sipponen T, Karkkainen P, Kolho KL, Saarialho-Kere U (2009) Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn’s disease after immunosuppressive treatment correlate with histological score and calprotectin values. Int J Colorectal Dis 24(10):1157–1167
Manousou P, Kolios G, Valatas V, Drygiannakis I, Bourikas L, Pyrovolaki K et al (2010) Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies. Clin Exp Immunol 162(2):337–347
Matsumoto S, Hara T, Hori T, Mitsuyama K, Nagaoka M, Tomiyasu N et al (2005) Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 140(3):417–426
Matsumoto S, Watanabe N, Imaoka A, Okabe Y (2001) Preventive effects of Bifidobacterium-and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence-accelerated mouse P1/Yit strain mice. Digestion 64(2):92–99
Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122(1):107–118
Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453(7195):620–625
McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ et al (2007) MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 117(8):2313–2324
McCarroll SA, Huett A, Kuballa P, Chilewski SD, Landry A, Goyette P et al (2008) Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn’s disease. Nat Genet 40(9):1107–1112
Menard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, Heyman M (2004) Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53(6):821–828
Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N et al (2009) Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 296(5):G1140–G1149
Meuwis MA, Fillet M, Geurts P, de Seny D, Lutteri L, Chapelle JP et al (2007) Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochem Pharmacol 73(9):1422–1433
Meuwis MA, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Piver E et al (2013) Serum calprotectin as a biomarker for Crohn’s disease. J Crohns Colitis 7(12):e678–e683
Micchelli CA, Perrimon N (2006) Evidence that stem cells reside in the adult Drosophila midgut epithelium. Nature 439(7075):475–479
Min SB, Le-Carlson M, Singh N, Nylund CM, Gebbia J, Haas K et al (2013) Video capsule endoscopy impacts decision making in pediatric IBD: a single tertiary care center experience. Inflamm Bowel Dis 19(10):2139–2145
Misra A, Rastogi K, Joshi SR (2009) Whole grains and health: perspective for Asian Indians. J Assoc Physicians India 57:155–162
Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, Managlia E et al (2011) Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 108(Suppl 1):4623–4630
Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142(1):46–54
Momotani E, Ozaki H, Hori M, Yamamoto S, Kuribayashi T, Eda S et al (2012) Mycobacterium avium subsp. paratuberculosis lipophilic antigen causes Crohn’s disease-type necrotizing colitis in mice. Springerplus 1(1):47
Monceaux CP, Testerman TL, Boktor M, Jordan P, Adegboyega P, McGee DJ et al (2013) Helicobacter infection decreases basal colon inflammation, but increases disease activity in experimental IBD. Open J Gastroenterology 3:177
Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT (2001) Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. J Clin Invest 108(4):601–609
Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV et al (2012) Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13(9):R79
Mortha A, Chudnovskiy A, Hashimoto D, Bogunovic M, Spencer SP, Belkaid Y et al (2014) Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 343(6178):1249288
Mow WS, Vasiliauskas EA, Lin YC, Fleshner PR, Papadakis KA, Taylor KD et al (2004) Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease. Gastroenterology 126(2):414–424
Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R et al (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut 60(5):571–607
Murano T, Okamoto R, Ito G, Nakata T, Hibiya S, Shimizu H et al (2014) Hes1 promotes the IL-22-mediated antimicrobial response by enhancing STAT3-dependent transcription in human intestinal epithelial cells. Biochem Biophys Res Commun 443(3):840–846
Nehme NT, Liegeois S, Kele B, Giammarinaro P, Pradel E, Hoffmann JA et al (2007) A model of bacterial intestinal infections in Drosophila melanogaster. PLoS Pathog 3(11):e173
Nerich V, Monnet E, Etienne A, Louafi S, Ramee C, Rican S et al (2006) Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis 12(3):218–226
Neurath MF (2014) Cytokines in inflammatory bowel disease. Nat Rev Immunol 14(5):329–342
Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H et al (2002) The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn’s disease. J Exp Med 195(9):1129–1143
Nguyen GC, Munsell M, Harris ML (2008) Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis 14(8):1105–1111
Nielsen OH, Munck LK (2007) Drug insight: aminosalicylates for the treatment of IBD. Nat Clin Pract Gastroenterol Hepatol 4(3):160–170
Niess JH, Danese S (2014) Anti-TNF and skin inflammation in IBD: a new paradox in gastroenterology? Gut 63(4):533–535
Nishimura T, Andoh A, Inatomi O, Shioya M, Yagi Y, Tsujikawa T et al (2008) Amphiregulin and epiregulin expression in neoplastic and inflammatory lesions in the colon. Oncol Rep 19(1):105–110
Ocon B, Anzola A, Ortega-Gonzalez M, Zarzuelo A, Suarez MD, Sanchez de Medina F et al (2013) Active hexose-correlated compound and Bifidobacterium longum BB536 exert symbiotic effects in experimental colitis. Eur J Nutr 52(2):457–466
Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411(6837):603–606
Ohlstein B, Spradling A (2006) The adult Drosophila posterior midgut is maintained by pluripotent stem cells. Nature 439(7075):470–474
Ohtani K, Ohtsuka Y, Ikuse T, Baba Y, Yamakawa Y, Aoyagi Y et al (2010) Increased mucosal expression of GATA-3 and STAT-4 in pediatric ulcerative colitis. Pediatr Int 52(4):584–589
Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98(3):694–702
Okumura T, Takeda K, Taniguchi K, Adachi-Yamada T (2014) betanu integrin inhibits chronic and high level activation of JNK to repress senescence phenotypes in Drosophila adult midgut. PLoS ONE 9(2):e89387
O’Mahony C, Scully P, O’Mahony D, Murphy S, O’Brien F, Lyons A, Sherlock G, MacSharry J, Kiely B, Shanahan F, O’Mahony L (2008) Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog 4(8):e1000112
Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M (1995) Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci U S A 92(10):4482–4486
Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UR et al (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53(5):685–693
Ou G, Rompikuntal PK, Bitar A, Lindmark B, Vaitkevicius K, Wai SN et al (2009) Vibrio cholerae cytolysin causes an inflammatory response in human intestinal epithelial cells that is modulated by the PrtV protease. PLoS ONE 4(11):e7806
Paik J, Fierce Y, Treuting PM, Brabb T, Maggio-Price L (2013) High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a-/- male mice. J Nutr 143(8):1240–1247
Pal A (2014) Crohn’s disease. InnovAiT Educ Inspiration Gen Pract 7(1):43–54
Panayidou S, Apidianakis Y (2013) Regenerative inflammation: lessons from Drosophila intestinal Epithelium in health and disease. Pathogens 2(2):209–231
Panayidou S, Ioannidou E, Apidianakis Y (2014) Human pathogenic bacteria, fungi, and viruses in Drosophila: disease modeling, lessons, and shortcomings. Virulence 5(2):253–269
Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J et al (2008) New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol 103(3):665–681
Parvez S, Malik KA, Ah Kang S, Kim HY (2006) Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 100(6):1171–1185
Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Adrio JL et al (2006) Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int J Colorectal Dis 21(8):737–746
Peterson LW, Artis D (2014) Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 14(3):141–153
Philippe D, Favre L, Foata F, Adolfsson O, Perruisseau-Carrier G, Vidal K et al (2011a) Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis. World J Gastroenterol 17(4):459–469
Philippe D, Heupel E, Blum-Sperisen S, Riedel CU (2011b) Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis. Int J Food Microbiol 149(1):45–49
Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M et al (2009) STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 206(7):1465–1472
Pinsk V, Lemberg DA, Grewal K, Barker CC, Schreiber RA, Jacobson K (2007) Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol 102(5):1077–1083
Pittschieler K (1990) Cow’s milk protein-induced colitis in the breast-fed infant. J Pediatr Gastroenterol Nutr 10(4):548–549
Plevy SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, Shealy D et al (1997) A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn’s disease. J Immunol 159(12):6276–6282
Pohl C, Hombach A, Kruis W (2000) Chronic inflammatory bowel disease and cancer. Hepatogastroenterology 47(31):57–70
Pouyet L, Roisin-Bouffay C, Clement A, Millet V, Garcia S, Chasson L et al (2010) Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model. Inflamm Bowel Dis 16(1):96–104
Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL (1994) Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4 + T cells. Immunity 1(7):553–562
Prefontaine E, Macdonald JK, Sutherland LR (2009) Azathioprine or 6-mercaptopurine for induction of remission in Crohn’s disease. Cochrane Database Syst Rev (4):CD000545
Prescott NJ, Fisher SA, Franke A, Hampe J, Onnie CM, Soars D et al (2007) A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn’s disease and is independent of CARD15 and IBD5. Gastroenterology 132(5):1665–1671
Radford-Smith GL, Edwards JE, Purdie DM, Pandeya N, Watson M, Martin NG et al (2002) Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn’s disease. Gut 51(6):808–813
Ragab A, Buechling T, Gesellchen V, Spirohn K, Boettcher AL, Boutros M (2011) Drosophila Ras/MAPK signalling regulates innate immune responses in immune and intestinal stem cells. EMBO J 30(6):1123–1136
Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T (1997) Pre-illness dietary factors in inflammatory bowel disease. Gut 40(6):754–760
Rhee KJ, Wu S, Wu X, Huso DL, Karim B, Franco AA et al (2009) Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun 77(4):1708–1718
Riley JK, Takeda K, Akira S, Schreiber RD (1999) Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem 274(23):16513–16521
Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro GM et al (2005) Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 6(5):507–514
Roggenbuck D, Hausdorf G, Martinez-Gamboa L, Reinhold D, Buttner T, Jungblut PR et al (2009) Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn’s disease. Gut 58(12):1620–1628
Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9(5):313–323
Round JL, Mazmanian SK (2010) Inducible Foxp3 + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 107(27):12204–12209
Ruiz-Perez B, Chung DR, Sharpe AH, Yagita H, Kalka-Moll WM, Sayegh MH et al (2005) Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. Proc Natl Acad Sci U S A 102(46):16753–16758
Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J et al (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353(23):2462–2476
Ryu JH, Kim SH, Lee HY, Bai JY, Nam YD, Bae JW et al (2008) Innate immune homeostasis by the homeobox gene caudal and commensal-gut mutualism in Drosophila. Science 319(5864):777–782
Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T et al (2008) Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456(7219):264–268
Saitoh S, Noda S, Aiba Y, Takagi A, Sakamoto M, Benno Y et al (2002) Bacteroides ovatus as the predominant commensal intestinal microbe causing a systemic antibody response in inflammatory bowel disease. Clin Diagn Lab Immunol 9(1):54–59
Sakamoto N, Kono S, Wakai K, Fukuda Y, Satomi M, Shimoyama T et al (2005) Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 11(2):154–163
Santos Rocha C, Gomes-Santos AC, Garcias Moreira T, de Azevedo M, Diniz Luerce T, Mariadassou M et al (2014) Local and systemic immune mechanisms underlying the anti-colitis effects of the dairy bacterium Lactobacillus delbrueckii. PLoS ONE 9(1):e85923
Sartor RB (2006) Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3(7):390–407
Scharl M, Rogler G (2012) Inflammatory bowel disease: dysfunction of autophagy? Dig Dis 30(Suppl 3):12–19
Schmidt RL, Trejo TR, Plummer TB, Platt JL, Tang AH (2008) Infection-induced proteolysis of PGRP-LC controls the IMD activation and melanization cascades in Drosophila. FASEB J 22(3):918–929
Schneider DS, Ayres JS, Brandt SM, Costa A, Dionne MS, Gordon MD et al (2007) Drosophila eiger mutants are sensitive to extracellular pathogens. PLoS Pathog 3(3):e41
Schreiber S, Rosenstiel P, Hampe J, Nikolaus S, Groessner B, Schottelius A et al (2002) Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 51(3):379–385
Schultz M, Veltkamp C, Dieleman LA, Grenther WB, Wyrick PB, Tonkonogy SL et al (2002) Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 8(2):71–80
Sears CL, Garrett WS (2014) Microbes, microbiota, and colon cancer. Cell Host Microbe 15(3):317–328
Selvam R, Maheswari P, Kavitha P, Ravichandran M, Sas B, Ramchand CN (2009) Effect of Bacillus subtilis PB6, a natural probiotic on colon mucosal inflammation and plasma cytokines levels in inflammatory bowel disease. Indian J Biochem Biophys 46(1):79–85
Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W et al (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110(9):3507–3512
Sgouras DN, Panayotopoulou EG, Martinez-Gonzalez B, Petraki K, Michopoulos S, Mentis A (2005) Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice. Clin Diagn Lab Immunol 12(12):1378–1386
Shaw SY, Blanchard JF, Bernstein CN (2010) Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol 105(12):2687–2692
Shea-Donohue T, Thomas K, Cody MJ, Aiping Z, Detolla LJ, Kopydlowski KM et al (2008) Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun 14(2):117–124
Shiba T, Aiba Y, Ishikawa H, Ushiyama A, Takagi A, Mine T et al (2003) The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. Microbiol Immunol 47(6):371–378
Shin SC, Kim SH, You H, Kim B, Kim AC, Lee KA et al (2011) Drosophila microbiome modulates host developmental and metabolic homeostasis via insulin signaling. Science 334(6056):670–674
Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L et al (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut 39(5):690–697
Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR et al (2008) Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog 4(10):e1000184
Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 montreal world congress of gastroenterology. Can J Gastroenterol 19(Suppl A):5A–36A
Simpson SJ, Shah S, Comiskey M, de Jong YP, Wang B, Mizoguchi E et al (1998) T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J Exp Med 187(8):1225–1234
Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE et al (1996) Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111(4):871–885
Singh SB, Ornatowski W, Vergne I, Naylor J, Delgado M, Roberts E et al (2010) Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria. Nat Cell Biol 12(12):1154–1165
Small CL, Reid-Yu SA, McPhee JB, Coombes BK (2013) Persistent infection with Crohn’s disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat Commun 4:1957
Snoeks L, Weber CR, Wasland K, Turner JR, Vainder C, Qi W et al (2009) Tumor suppressor FOXO3 participates in the regulation of intestinal inflammation. Lab Invest 89(9):1053–1062
Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ et al (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105(43):16731–16736
Solem CA, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ (2005) Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 11(8):707–712
Song J, Medline A, Mason JB, Gallinger S, Kim YI (2000) Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res 60(19):5434–5440
Staley BK, Irvine KD (2010) Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation. Curr Biol 20(17):1580–1587
Stecher B, Paesold G, Barthel M, Kremer M, Jantsch J, Stallmach T et al (2006) Chronic Salmonella enterica serovar Typhimurium-induced colitis and cholangitis in streptomycin-pretreated Nramp1 +/+ mice. Infect Immun 74(9):5047–5057
Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, Koch WA et al (2004) Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36(5):476–480
Sturlan S, Oberhuber G, Beinhauer BG, Tichy B, Kappel S, Wang J et al (2001) Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development. Carcinogenesis 22(4):665–671
Su L, Shen L, Clayburgh DR, Nalle SC, Sullivan EA, Meddings JB et al (2009) Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology 136(2):551–563
Szanto I, Rubbia-Brandt L, Kiss P, Steger K, Banfi B, Kovari E et al (2005) Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 207(2):164–176
Szilagyi A, Leighton H, Burstein B, Xue X (2014) Latitude, sunshine, and human lactase phenotype distributions may contribute to geographic patterns of modern disease: the inflammatory bowel disease model. Clin Epidemiol 6:183–198
Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I et al (1999) Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10(1):39–49
Tanaka S, Kobayashi T, Songjinda P, Tateyama A, Tsubouchi M, Kiyohara C et al (2009) Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol 56(1):80–87
Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H (2003) A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 94(11):965–973
Tao Y, Drabik KA, Waypa TS, Musch MW, Alverdy JC, Schneewind O et al (2006) Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 290(4):C1018–C1030
Tarrant KM, Barclay ML, Frampton CM, Gearry RB (2008) Perianal disease predicts changes in Crohn’s disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol 103(12):3082–3093
Tlaskalova-Hogenova H, Stepankova R, Kozakova H, Hudcovic T, Vannucci L, Tuckova L et al (2011) The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 8(2):110–120
Todhunter CE, Sutherland-Craggs A, Bartram SA, Donaldson PT, Daly AK, Francis RM et al (2005) Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn’s disease. Gut 54(11):1579–1584
Tokuyama H, Ueha S, Kurachi M, Matsushima K, Moriyasu F, Blumberg RS et al (2005) The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis. Int Immunol 17(8):1023–1034
Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T et al (2006) A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 12(8):782–786
Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D et al (1993) Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 104(3):741–748
Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1:6ra14
Tzelepis I, Kapsetaki SE, Panayidou S, Apidianakis Y (2013) Drosophila melanogaster: a first step and a stepping-stone to anti-infectives. Curr Opin Pharmacol 13(5):763–768
Uchida M, Mogami O, Matsueda K (2007) Characteristic of milk whey culture with Propionibacterium freudenreichii ET-3 and its application to the inflammatory bowel disease therapy. Inflammopharmacology 15(3):105–108
Uematsu S, Jang MH, Chevrier N, Guo Z, Kumagai Y, Yamamoto M et al (2006) Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c + lamina propria cells. Nat Immunol 7(8):868–874
Ueno N, Fujiya M, Segawa S, Nata T, Moriichi K, Tanabe H et al (2011) Heat-killed body of lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function. Inflamm Bowel Dis 17(11):2235–2250
UK IBD Genetics Consortium, Barrett JC, Lee JC, Lees CW, Prescott NJ, Anderson CA et al (2009) Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 41(12):1330–1334
Valentin-Vega YA, Okano H, Lozano G (2008) The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival. Cell Death Differ 15(11):1772–1781
van Es JH, Clevers H (2005) Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease. Trends Mol Med 11(11):496–502
van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM et al (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368(5):407–415
Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S et al (2002) Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295(5560):1726–1729
Vilaseca J, Salas A, Guarner F, Rodriguez R, Martinez M, Malagelada JR (1990) Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 31(5):539–544
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M et al (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319(9):525–532
von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S (2000) Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47(1):63–73
Wagner J, Catto-Smith AG, Cameron DJ, Kirkwood CD (2013) Pseudomonas infection in children with early-onset Crohn’s disease: an association with a mutation close to PSMG1. Inflamm Bowel Dis 19(4):E58–E59
Walker DG, Bancil AS, Williams HR, Bunn C, Orchard TR (2011) How helpful are serological markers in differentiating crohn’s disease from ulcerative colitis in indian asian inflammatory bowel disease patients? Gut 60(Suppl 1):A222–A223
Wang C, Zhao R, Huang P, Yang F, Quan Z, Xu N et al (2013) APC loss-induced intestinal tumorigenesis in Drosophila: Roles of Ras in Wnt signaling activation and tumor progression. Dev Biol 378(2):122–140
Wehkamp J, Harder J, Weichenthal M, Mueller O, Herrlinger KR, Fellermann K et al (2003) Inducible and constitutive beta-defensins are differentially expressed in Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis 9(4):215–223
Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE et al (2005) Reduced paneth cell alpha-defensins in ileal Crohn’s disease. Proc Natl Acad Sci U S A 102(50):18129–18134
Wirtz S, Neurath MF (2007) Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 59(11):1073–1083
Wittkopf N, Billmeier U, Günther C, Wirtz SJ, Neurath MF, Becker C (2011) STAT3-mediated production of antimicrobial peptides by intestinal epithelial cells helps controlling C. rodentium induced infection. Gastroenterology 140(5, Supplement 1):S-325
Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ (2006) Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40(3):235–243
Wu H, Wang MC, Bohmann D (2009a) JNK protects Drosophila from oxidative stress by trancriptionally activating autophagy. Mech Dev 126(8–9):624–637
Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR et al (2009b) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15(9):1016–1022
Wu Y, Antony S, Hewitt SM, Jiang G, Yang SX, Meitzler JL et al (2013) Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal antibody. Int J Oncol 42(4):1229–1238
Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448(7152):427–434
Xu N, Wang SQ, Tan D, Gao Y, Lin G, Xi R (2011) EGFR, wingless and JAK/STAT signaling cooperatively maintain Drosophila intestinal stem cells. Dev Biol 354(1):31–43
Yan B, Wang H, Rabbani ZN, Zhao Y, Li W, Yuan Y et al (2006) Tumor Necrosis Factor-α is a potent endogenous Mutagen that promotes cellular transformation. Cancer Res 66(24):11565–11570
Zaidman-Remy A, Herve M, Poidevin M, Pili-Floury S, Kim MS, Blanot D et al (2006) The Drosophila amidase PGRP-LB modulates the immune response to bacterial infection. Immunity 24(4):463–473
Zaph C, Troy AE, Taylor BC, Berman-Booty LD, Guild KJ, Du Y et al (2007) Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 446(7135):552–556
Ze X, Duncan SH, Louis P, Flint HJ (2012) Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 6(8):1535–1543
Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA (2008) Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29(6):947–957
Zhernakova A, Festen EM, Franke L, Trynka G, van Diemen CC, Monsuur AJ et al (2008) Genetic analysis of innate immunity in Crohn’s disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am J Hum Genet 82(5):1202–1210
Zhou FX, Chen L, Liu XW, Ouyang CH, Wu XP, Wang XH et al (2012) Lactobacillus crispatus M206119 exacerbates murine DSS-colitis by interfering with inflammatory responses. World J Gastroenterol 18(19):2344–2356
Zindl CL, Lai J, Lee YK, Maynard CL, Harbour SN, Ouyang W et al (2013) IL-22–producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci 110:12768–12773
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Theodoulakis, C., Apidianakis, Y. (2015). Parallels Between Mammals and Flies in Inflammatory Bowel Disease. In: Vaiserman, A., Moskalev, A., Pasyukova, E. (eds) Life Extension. Healthy Ageing and Longevity, vol 3. Springer, Cham. https://doi.org/10.1007/978-3-319-18326-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-18326-8_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18325-1
Online ISBN: 978-3-319-18326-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)